- 专利标题: BISAMIDE SARCOMERE ACTIVATING COMPOUNDS AND USES THEREOF
-
申请号: US16833321申请日: 2020-03-27
-
公开(公告)号: US20200223829A1公开(公告)日: 2020-07-16
- 发明人: Luke Ashcraft , Alessandro Boezio , John Butler , Aroop Chandra , Chihyuan Chuang , Scott E. Collibee , Mikkel V. Debenedetto , Vincent DiMassa , Russell Graceffa , Justin Malinowski , David Moebius , Bradley Paul Morgan , Joshua Payette , Antonio Romero , David St. Jean, JR. , Richard Vargas , John Yeoman , Hanmo Zhang , Alan Cheng , Felix Gonzalez Lopez De Turiso , Michael Garrett Johnson
- 申请人: AMGEN INC. , CYTOKINETICS, INC.
- 主分类号: C07D403/12
- IPC分类号: C07D403/12 ; C07D401/14 ; C07D401/12 ; A61P9/00 ; C07D413/14 ; C07D207/16 ; C07D209/52 ; C07D405/12 ; C07D417/14 ; C07D401/06 ; C07D403/14 ; C07D209/02 ; C07D413/12
摘要:
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising a compound of the invention, a method for manufacturing compounds of the invention and therapeutic uses thereof.
公开/授权文献
- US11254658B2 Bisamide sarcomere activating compounds and uses thereof 公开/授权日:2022-02-22
信息查询